Clinical Trial Update: Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, efficacy, and tolerability of up to 20 mL of DFA-02 for prevention of surgical site infections in patients undergoing abdominal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infections

Drugs mentioned

• DFA-02

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Surgical Site Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-10-11